Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis

BACKGROUND: Although combination therapy using clarithromycin, rifampicin, and ethambutol is recommended for patients with pulmonary Mycobacterium avium complex (MAC) disease, some patients do not tolerate it because of adverse effects or underlying diseases. The efficacy and safety of fluoroquinolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuto, Hisayuki, Komiya, Kosaku, Goto, Akihiko, Kan, Takamasa, Honjo, Kokoro, Uchida, Sonoe, Takikawa, Shuichi, Yoshimatsu, Tetsuyuki, Yamasue, Mari, Hiramatsu, Kazufumi, Kadota, Jun-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347193/
https://www.ncbi.nlm.nih.gov/pubmed/32645105
http://dx.doi.org/10.1371/journal.pone.0235797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347193/
https://www.ncbi.nlm.nih.gov/pubmed/32645105
http://dx.doi.org/10.1371/journal.pone.0235797

Ejemplares similares